期刊文献+

砷暴露人群的砷甲基化水平及其影响因素的Meta分析 被引量:12

Factors affecting arsenic methylation in arsenic-exposed humans: a systematic review and Meta-analysis
原文传递
导出
摘要 目的探讨砷暴露对机体砷甲基化代谢水平的调控及其影响因素,为研究砷甲基化代谢在砷毒性机制中的作用提供参考。方法由两名研究者共同进行Meta分析,通过数据库Cochranelibrary、Pubmed、Springer、Embase、中国知网(CNKI)检索,最终纳人符合标准的文献25篇,根据异质性检验结果,采用随机效应模型或固定效应模型进行综合的定量分析。结果砷暴露人群尿液中砷代谢物含量:无机砷[iAs:标准化均数差(SMD):1.07;95%置信区间(CI):0.61—1.53]、一甲基砷酸(MMA;SMD:1.10;95%CI:0.81-1.40)、二甲基砷酸(DMA;SMD:2.50;95%CI:1.50—3.69)、总砷(TAs;SMD:3.10;95%CI:2.13—4.07)均明显增加(P均〈0.01)。砷代谢物比例指标:iAs%(SMD:1.00;95%CI:0.60-1.40)、MMA%(SMD:0.49;95%CI:0.21-0.77)均明显升高,DMA%(SMD:-0.55;95%CI:-0.80--0.31)明显下降(P均〈0.01)。甲基率指标:一甲基率(PMI;SMD:-0.57;95%CI:-0.94--0.20)、二甲基率(SMI;SMD:-0.27;95%CI:-0.46--0.09)均明显下降(P均〈0.01)。与女性比较,男性尿砷中MMA%(SMD:0.44;95%CI:0.35-0.52)明显升高,DMA%(SMD:-0.33:95%CI:-0.38--0.28)、SMI(SMD:-0.36;95%CI:-0.53--0.19)明显降低;与非吸烟者比较,吸烟者MMA%(SMD:0.22;95%CI:0.07-0.37)明显升高,DMA%(SMD:-0.16;95%CI:-0.26--0.05)明显降低;与非饮酒者比较,饮酒者MMA%(SMD:0.17;95%CI:0.07-0.27)明显升高,DMA%(SMD:-0.24;95%CI:-0.39--0.10)明显降低;与〉50岁者比较,≤50岁者MMA%(SMD:-0.23;95%CI:-0.40--0.06)明显降低;体质指数(BMI)明显影响MMA%(SMD:-0.18;95%CI:-0.3l—-0.04),差异有统计学意义(P均〈0.01)。结论砷暴露、吸烟、饮酒及高龄都可以降低机体砷甲基化能力,女性砷甲基化能力较男性更为有效。 Objective To explore the regulation and effect factors of arsenic expose and arsenic methylation level, then to provide a reference for study the function of arsenic metabolism in a arsenic poisoning process. Methods A meta-analysis was performed by two researchers. Twenty-five papers satisfying our priori eligibility criteria were included by searching Cochrane library, Pubmed, Springer, Embase and China National Knowledge Inf:astructure. Based on the results of heterogeneity, a random or fixed effects model was chosen for the meta-analysis. Results The results showed that the following arsenic metabolites increased (all P 〈 0.01) following arsenic exposure: inorganic arsenic [iAs; standardized mean difference (SMD): 1.07; 95% confidence interval (CI): 0.61 - 1.53)], monomethyl arsenic (MMA; SMD: 1.10; 95% CI: 0.81 - 1.40), dimethyl arsenic (DMA; SMD: 2.50; 95% CI: 1.50 -- 3.69), and total arsenic (TAs, SMD: 3.10; 95% CI: 2.13 - 4.07). Additionally, the percentages of iAs (iAs%; SMD: 1.00; 95% CI: 0.60 - 1.40) and MMA (MMA%; SMD: 0.49; 95% CI: 0.21 - 0.77) also increased, while the percentage of DMA (DMA%; SMD: - 0.55; 95% CI: - 0.80 - - 0.31) decreased (P 〈 0.01). The primary methylation index (PMI; SMD: - 0.57; 95% CI: - 0.94 - - 0.20), and secondary methylation index (SMI;SMD: - 0.27; 95% CI: - 0.46 - - 0.09) decreased (all P 〈 0.01). Compared to female, male had higher MMA% (SMD: 0.44; 95% CI: 0.35 - 0.52), lower DMA% (SMD: - 0.33; 95% CI: - 0.38 - - 0.28) and SMI (SMD: - 0.36; 95% CI.- 0.53 - - 0.19). The smoker had higher MMA% (SMD: 0.22; 95% CI: 0.07 - 0.37) and lower DMA% (SMD: - 0.16; 95% CI: - 0.26 - - 0.05). The drinker had higher MMA% (SMD: 0.17; 95% CI: 0.07 - 0.27) and lower DMA% (SMD: - 0.24; 95% CI: - 0.39 - - 0.10). The older people had higher MMA% (SMD: - 0.23; 95%CI: - 0.40 - - 0.06). In addition, the body mass index may influence the percentages of MMA (SMD: - 0.18; 95% CI: - 0.31 - - 0.04, P 〈 0.01). Conclusion Arsenic exposure, smoking, drinking, and older age can reduce the capacity of arsenic methylation. Arsenic methylation is more efficient in women than in men.
出处 《中华地方病学杂志》 CAS CSCD 北大核心 2016年第12期869-874,共6页 Chinese Journal of Endemiology
基金 国家自然科学基金(81560517) 兵团应用基础项目(2015AG014) 兵团重点领域科技攻关项目(2014BA039)
关键词 甲基化 META分析 人类 Arsenic Methylation Meta-analysis Humans
  • 相关文献

参考文献2

二级参考文献18

  • 1徐苑苑,李昕,梁秀芬,金亚平,陆春伟,李革新,孙贵范.内蒙古不同浓度砷暴露人群尿砷代谢产物研究[J].中国公共卫生,2006,22(8):956-957. 被引量:18
  • 2Sun GF, Xu YY, Li X,et al. Urinary arsenic metabolites in children and adults exposed to arsenic in dr:inking water in Inner Mongolia, China [J ]. Environ Health Perspect,2007,115:648-652.
  • 3Vahter M, Concha G. Role of metabolism in arsenic [J]. Pharmacol Toxicol,2001,89:1-5.
  • 4Vahter M. Mechanisms of arsenic biotransformation [J]. Toxicology, 2002,181- 182:211-217.
  • 5Xu YY, Wang Y,Zheng QM, et al . Association of oxidative stress with arsenic methylation in chronic arsenic-exposed children and adults [J]. Toxicol Appl Pharmacol, 2008,232:142-149.
  • 6Tseng CH, Huang YK, Huang YL, et al. As exposure, urinary As speciation, and peripheral vascular disease in blackfoot disease hyperendemic villages in Taiwan [J]. Toxicol Appl Pharmacol, 2005, 206: 299-308.
  • 7Chen, Y. C. , Y.L. Guo, H.J. Su, et al. Arsenic methylation and skin cancer risk in southwestern Taiwan [ J]. J Occup Environ Med,2003,45(3) : 241 -248.
  • 8Chiou, H.Y. , Y.M. Hsueh, L.L. Hsieh, et al. Arsenic methylation capacity, body retention, and null genotypes of glutathione S - transferase MI and T1 among current arsenic - exposed residents in Taiwan[ J]. Mutat Res, 1997,386 (3) : 197 - 207.
  • 9McCarty KM, Chen YC, Quararuzzaman Q, et al. Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms, and skin lesions[J]. Environ Health Perspect ,2007,115 ( 3 ) :341 - 345.
  • 10Vahter, M. Mechanisms of arsenic biotransformation [ J]. Toxicology, 2002,(181-182): 211 -217.

共引文献14

同被引文献124

引证文献12

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部